Rchr
J-GLOBAL ID：202001014798242951
Update date: Mar. 09, 2026
Sudo Kazuki
スドウ カズキ | Sudo Kazuki
Affiliation and department：
Other affiliations (3)：
-
National Cancer Center
-
National Cancer Center
-
National Cancer Center
Research field (1)：
Tumor diagnostics and therapeutics
Research keywords (5)：
臨床腫瘍学
, 国際共同研究
, TR
, 臨床試験
, 治験
Research theme for competitive and other funds (1)：
- FGFR遺伝子異常を有する進行・再発固形がんに対するFGFR阻害薬単剤療法の医師主導治験のプロトコール作成
Papers (148)：
-
Ryuji Hamamoto, Takafumi Koyama, Satoshi Takahashi, Tomohiro Yasuda, Kazuma Kobayashi, Yu Akagi, Nobuji Kouno, Kazuki Sudo, Makoto Hirata, Kuniko Sunami, et al. Implementing generative artificial intelligence in precision oncology: safety, governance, and significance. Journal of Hematology & Oncology. 2026. 19. 1
-
Shu Yazaki, Rui Kitadai, Yukihide Momozawa, Teruhiko Yoshida, Takashi Yamanaka, Sho Shiino, Chisako Yamauchi, Kenichi Harano, Motonobu Saito, Yosuke Hirotsu, et al. Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer. NPJ breast cancer. 2025. 11. 1. 133-133
-
Mai Hoshino, Tatsunori Shimoi, Taro Yamanaka, Rui Kitadai, Munehiro Ito, Ayumi Saito, Shosuke Kita, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Aiko Maejima, et al. Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer. Breast cancer (Tokyo, Japan). 2025
-
山口 祐平, 星野 舞, 下井 辰徳, 野口 瑛美, 山中 太郎, 北台 留衣, 齋藤 亜由美, 大熊 ひとみ, 小島 勇貴, 須藤 一起, et al. ベンタナHER2(4B5)とDAKO HercepTestのスコア不一致に関わる臨床病理学的因子の検討. 日本乳癌学会総会プログラム抄録集. 2025. 33回. 366-366
-
Mai Onishi, Tatsunori Shimoi, Shu Yazaki, Yuki Kojima, Taro Yamanaka, Rui Kitadai, Mai Hoshino, Munehiro Ito, Ayumi Saito, Shosuke Kita, et al. Abstract P2-05-26: Differential TROP2 expression patterns among inflamed tumor microenvironments in HER2-negative breast cancer. Clinical Cancer Research. 2025. 31. 12_Supplement. P2-05
ｍore...
MISC (84)：
-
阿部, 祥歩, 安田, 知弘, 小山, 隆文, 角南, 久仁子, 久保, 崇, 平田, 真, 須藤, 一起, 田尾, 佳代子, 浜本, 隆二. 臨床応用を見据えた遺伝子変異の病的意義判定AIの開発. 第86回全国大会講演論文集. 2024. 2024. 1. 311-312
-
MAEJIMA Aiko, AIBA Hisaki, YAMANAKA Taro, KITADAI Rui, SAITO Ayumi, KITA Shosuke, KOJIMA Yuki, NISHIKAWA Tadaaki, SHIMOI Tatsunori, SUDO Kazuki, et al. Clinical Characteristic of the diagnosis and treatment of primary Ewing’s sarcoma of the kidney. 日本泌尿器科学会総会(Web). 2024. 111th
-
KITADAI Rui, SHIMOI Tatsunori, ONISHI Mai, YAMANAKA Taro, HOSHINO Mai, ITO Munehiro, KAWACHI Asuka, OKUMA Hitomi, SAITO Ayumi, KITA Shosuke, et al. Prognostic impact of HER2-low status in metastatic triple negative breast cancer (mTNBC) treated with ICI. 日本臨床腫瘍学会学術集会(CD-ROM). 2024. 21st
-
齋藤亜由美, 下井辰徳, 大西舞, 山中太郎, 北台留衣, 星野舞, 大熊ひとみ, 小島勇貴, 西川忠暁, 須藤一起, et al. HER2低発現乳癌におけるHER2発現状況の変化とT-DXdの有効性の検討. 日本乳癌学会学術総会(CD-ROM). 2024. 32nd
-
IMAI Toru, SHIMOI Tatsunori, KOJIMA Yuki, KAWACHI Asuka, OKUMA SUMIYOSHI Hitomi, HOSHINO Mai, ITO Munehiro, SAITO Ayumi, KITA Shosuke, MAEJIMA Aiko, et al. Third-line chemotherapy for recurrent/refractory rhabdomyosarcoma in adults: a single-center retrospective study. 日本臨床腫瘍学会学術集会(CD-ROM). 2024. 21st
ｍore...
Return to Previous Page
